16
STRONGYLOIDIASIS ETIOLOGY: STRONGYLOIDES STERCORALIS

3STRONGYLOIDIASIS

Embed Size (px)

DESCRIPTION

Strongyloidiasis

Citation preview

  • STRONGYLOIDIASISETIOLOGY: STRONGYLOIDES STERCORALIS

  • PATHOGENESIS

    ABILITY OF S. S. TO REPLICATE WITHIN THE HOST IN CHRONIC STRONGYLOIDIASIS:* BALANCE BETWEEN HOST PARASITE

    WHERE WORMS RESTRICTED IN NUMBER

    HOST DEFENSES BREAK DOWN

    WORMS MULTIPLY RAPIDLY & DISSEMINATE THROUGHOUT THE BODY

    CUTANEOUS LESION HYPERSENSITIVITY Rx WORMS PRODUCTS ENTERITIS:DIRECT MECHANICAL TRAUMAINFLAMMTORY RxSECONDARY BACTERIAL COLONIZATION

  • CLINICAL MANIFESTATIONS (1)

    ACUTE STRONGYIDIASIS

    LARVAE THROUGHT THE LUNGSLOEFFLERS SYNDROM, COUGH, SHORTNESS OF BREATH, WHEEZING, FEVER, IN THE GUTABDOMINAL PAIN, DIARRHEA, EPIGASTRIC PAIN, MALABSORPSION

  • CHRONIC STRONGYLOIDIASIS- S.S. INFECTIONS > 35 YEARS * ASYMPTOMATIC * CUTANEOUS SYMP. * GASTROINTESTINAL SYMP. - THE CLASSIC TRIAD: ABDOMINAL PAIN DIARRHEA URTICARIA - CREEPING ERUPTION CLINICAL MAAANIFESTATIONS (2)

  • DISSEMINATED STRONGYLOIDIASIS (1) - OVERWHELMING STRONGYLOIDIASIS - IMMUNOSUPRESSED RESULT OF DISEASES - IMMUNOSUPRESSIVE AGENTS - MALNUTRITION - PATIENTS WITH BURN - CHRONIC INFECTION - IRRADIATION - LYMPHOMAS - AIDS - SYSTEMIC CORTICOSTEROID THERAPY

  • DISSEMINATED STRONGYLOIDIASIS (2) - SEVERE, GENERALIZED ABDOMINAL PAIN - ABDOMINAL DISTENTION - SHOCK - ILEUS EDEMA SMALL-BOWEL OBSTRUCTION FATAL NECROTIZING JEJUNITIS - JAUNDICE

  • - MASSIVE LARVAL INVATION OF THE LUNG: * COUGH * WHEEZING * DYSPNEA - CEREBRAL INVOLMENT: * CHANGE IN MENTAL STATUS * COMA - HIGH FEVER DISSEMINATED STRONGYLOIDIASIS (3)

  • CLINICAL FINDINGS (1)1. CUTANEOUS MANIFESTATIONS - FOCAL EDEMA - INFLAMMATION - PETECHIAE - SERPIGIOUS OR URTICARIAL TRACT, AND INTENSE ICTHING - CREEPING ERUPTIONS CHRONIC

  • 2. INTESTINAL MANIFESTATIONS: MILD SEVERE - ANOREXIA - VOMITING - EPIGASTRIC TENDERNESS MIMIC DUODENAL ULCER - DIARRHEA DIARRGEA CONSTIPATION - ABDOMINAL PAIN - FLATULENCE - PRURITUS ANI - FECES CONTAIN MUCUS AND BLOOD - MALABSORPTION

    CLINICAL FINDINGS (2)

  • 3. PULMONAL MANIFESTATIONS - DRY COUGH - THROAT IRRITATION OR LOW-GRADE FEVER - DYSPNEA - WHEEZING - HEMOPTYSIS - ASTHMA CLINICAL FINDINGS (3)

  • CLINICAL FINDINGS (4) - BRONCHOPNEUMONIA - BRONCHITIS - PLEURAL EFFUSION - PROGRESSIVE DYSPNEA - MILIARY ABSCESSES - COUGH: * PRODUCTIVE OF AN ODORLESS * MUCOPURULENT SPUTUM

  • COMPLICATION: HYPERINFECTION (1)

    1. PLEURAL EFFUSION2. MYOCARDITIS3. HEPATIC GRANULOMAS4. CHOLECYSTITIS5. PURPURA6. ULCERATING LESIONS OF THE GI. TRACT7. CNS INVOLVEMENT

  • COMPLICATION: HYPERINFECTION (2)

    8. PARALYTIC ILEUS9. PERFORATION-PERITONITIS10. GRAM-NEGATIVE SEPTICEMIA11. MENINGITIS12. CACHEXIA13. SHOCK ABD DEATH14. NEPHROTIC SYNDROME

  • MANAGEMENT (1)

    * UNCOMPLICATED STRONGYLOIDIASIS- IVERMECTIN, 200 G/KG FOR 2 DAYS- THIABENDAZOLE, 25 MG/KGBW, TWICE DAYLY FOR 3 DAYS (MAX. 1,5 G PER DOSE), REPEAT IN 2 WEEKS- MEBENDAZOLE- CAMBENDAZOLE- ALBENDAZOLE, 2 X 400 MG FOR 3-7 DAYS, REPEATED IN 1 WEEK

  • * DISSEMINATED STRONGYLOIDIASIS - THIABENDAZOLE, 25 MG/KGBWTWICE DAYLY FOR 1 WEEK - REPEATED 25 MG/KGBW TWICE DAYLY FOR 2 DAYS AT MONTHLY INTERVALS

    MANAGEMENT (2)

  • PRGONOSIS

    PROGNOSIS IS FAVORABLE EXCEPT: * IN THE HYPERINFECTION * ASSOCITED WITH EMACIATON * ADVANCED LIVER DISEASE * CANCER * IMMUNOLOGIC DISORDERS * THE USE OFI MMUNOSUPPRESSIVE DRUGS